Use of human fibroblasts in the development of a xenobiotic-free culture and delivery system for human keratinocytes

Tissue Engineering

Volumn 12, Issue 2, 2006, Pages 245-255

  Bullock, Anthony J ^a   Higham, Michael C ^a   MacNeil, Sheila ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; GROWTH KINETICS; PHYSIOLOGICAL MODELS; POLYMERIZATION; PROTEINS; VACCINES;

FIBROPLASTS; KERATINOCYTES; SERUM; WOUNDS;

TISSUE CULTURE;

ACID; DNA; INVOLUCRIN; POLYMER; XENOBIOTIC AGENT;

ARTICLE; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL TRANSFER; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DERMIS; DISEASE MODEL; FETUS; GAMMA IRRADIATION; HUMAN; HUMAN CELL; KERATINOCYTE; LUNG FIBROBLAST; MONOCULTURE; PERFORMANCE; PLASMA; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN FIBROBLAST; WOUND;

CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; COCULTURE TECHNIQUES; COLLAGEN TYPE I; CULTURE MEDIA, SERUM-FREE; FIBROBLASTS; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FLUORESCENT DYES; GAMMA RAYS; HUMANS; KERATINOCYTES; MICROSCOPY, FLUORESCENCE; MITOMYCIN; POLYMERS; PROTEIN PRECURSORS; SUBSTRATE SPECIFICITY;

BOVINAE; MURINAE;

EID: 33645528574     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2006.12.245     Document Type: Article

References (24)

1. Higham, M.C., Dawson, R., Szabo, M., Short, R., Haddow, D.B., and MacNeil, S. Development of a stable chemically defined surface for the culture of human keratinocytes under serum-free conditions for clinical use. Tissue Eng. 9, 919, 2003.
2. France, R.M., Short, R.D., Dawson, R.A., and MacNeil, S. Attachment of human keratinocytes to plasma co-polymers of acrylic acid/octa-1,7-diene and allyl amine/octa-1,7-diene. J. Mater. Chem. 8, 37, 1998.
3. Haddow, D.B., Steele, D.A., Short, R.D., Dawson, R.A., and MacNeil, S. Plasma-polymerized surfaces for culture of human keratinocytes and transfer of cells to an in vitro wound-bed model. J. Biomed. Mater. Res. A64, 80, 2003.
4. Moustafa, M., Simpson, C., Glover, M., Dawson, R.A., Tesfaye, S., Creagh, M., Haddow, D.B., Short, R., Heller, S., and MacNeil, S. A new autologous keratinocyte based dressing treatment for non healing diabetic neuropathic foot ulcers. Diab.Med. 21, 786, 2004.
5. Zhu, N., Warner, R.M., Simpson, C., Glover, M., Hernon, C.A., Brotherstone, T.M., Ralston, D.R., Kelly, J., Fraser, S., and MacNeil, S. Treatment of burns and chronic wounds Uusing a new cell transfer dressing for delivery of autologous keratinocytes. In press.
6. Rheinwald, J.G., and Green, H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6, 331, 1975.
7. Jacobs, J.P., Jones, C.M., and Baille, J.P. Characteristics of a human diploid cell designated MRC-5. Nature 227, 168, 1970.
8. Jacobs, J.P. The status of human diploid cell strain MRC-5 as an approved substrate for the production of viral vaccines. J. Biol. Stand. 4, 97, 1976.
9. Rosolowsky, M., McKee, R., Nichols, W., and Garfinkle, B. Chromosomal characterization of MRC-5 cell banks utilizing G-banding technique. Dev. Biol. Stand. 93, 109, 1998.
10. Chakrabarty, K.H., Dawson, R.A., Harris, P., Layton, C., Babu, M., Could, L., Phillips, J., Leigh, I., Green, C., Freedlander, E., and MacNeil, S. Development of autologous human dermal-epidermal composites based on sterilized human allodermis for clinical use. Br. J. Dermatol. 141, 811, 1999.
11. Hudson, D.L., Weiland, K.L., Dooley, T.P., Simon, M., and Watt, P.M. Characterisation of eight monoclonal antibodies to involucrin. Hybridoma 11, 367, 1992.
12. Little, M.C., Gawkrodger, D.J., and MacNeil, S. Differentiation of human keratinocytes is associated with a progressive loss of interferon gamma-induced intercellular adhesion molecule-1 expression. Br. J. Dermatol. 135, 24, 1996.
13. Rao, J., and Otto, W.R. Fluorimetric DNA assay for cell growth estimation. Anal. Biochem. 207, 186, 1992.
14. Pye, R.J. Cultured keratinocytes as biological wound dressings. Eye 2 172, 1988.
15. Chester, D.L., Balderson, D.S., and Papini, R.P. A review of keratinocyte delivery to the wound bed. J. Burn Care Rehabil. 25, 266, 2004.
16. Wang, H.J., Chen, T.M., Cheng, L.F., Cheng, T.Y., and Tung, Y.M. Human keratinocyte culture using porcine pituitary extract in serum-free medium. Burns 21, 503, 1995.
17. Pedersen, N.S., and Smith, E. Prion diseases: epidemiology in man. APMIS 110, 14, 2002.
18. Rice, R.H., and Green, H. Presence in human epidermal cells of a soluble protein precursor of the cross-linked envelope: activation of the cross-linking by calcium ions. Cell 18, 681, 1979.
19. Watt, F.M., and Green, H. Stratification and terminal differentiation of cultured epidermal cells. Nature 295, 434, 1982.
20. Obedencio, O.P., Nuccitelli, R., and Isseroff, R.R. Involucrin-positive keratinocytes demonstrate decreased migration speed but sustained directional migration in a DC electric field. J. Invest, Dermatol. 113, 851, 1999.
21. Dvorankova, B., Holikova, Z., Vacik, J., Konigova, R., Kapounkova, Z., Michalek, J., Pradn, M., and Smetana, K., Jr. Reconstruction of epidermis by grafting of keratinocytes cultured on polymer support-clinical study. Int. J. Dermatol. 42, 219, 2003.
22. Dvorankova, B., Smetana, K., Konigova, R., Singerova, H., Vacik, J., Jelinkova, M., Kapounkova, Z., and Zahradnik, M. Cultivation and grafting of human keratinocytes on a poly(hydroxyethyl methacrylate) support to the wound bed: a clinical study. Biomaterials 19, 141, 1998.
23. Ralston, D.R., Layton, C., Dalley, A.J., Boyce, S.G., Freedlander, E., and MacNeil, S. The requirement for basement membrane antigens in the production of human epidermal/dermal composites in vitro. Br. J. Dermatol. 140, 605, 1999.
24. Sun, T., Higham, M., Layton, C., Haycock, J., Short, R., and MacNeil, S. Developments in xenobiotic-free culture of human keratinocytes for clinical use. Wound Repair Regen. 12, 626, 2004.